Database : HANSEN
Search on : ANTICORPOS ANTIBACTERIAS [Subject descriptor]
References found : 94 [refine]
Displaying: 1 .. 20   in format [Detailed]

page 1 de 5 go to page              

  1 / 94 HANSEN  
              next record last record
select
to print
Id:13935
Author:Jayapal, V; Selvibai, G; Mahalakshmi, K; Pushkala; Regunath, K; Subramanian, S
Title:Comparative study of anti-PGL-1, anti-35 kDa and anti-lipoarabinomannan assays for serodiagnosis of leprosy ..-
Source:s.l; s.n; 2001. 9 p. tab.
Abstract:Three antibody assays (anti-PGL-1, anti-35 kDa and anti-LAM) were used to determine the levels of antibodies in the sera of untreated leprosy patients. All the three assays showed higher levels of antibodies in BL/LL patients as compared to I and TT/BT patients, as well as healthy controls. BL/LL patients showed positivity of 100 per cent, 84.2 per cent and 78.9 per cent by anti-PGL-1, anti-35 kDa and anti-LAM assays respectively. All the three assays were negative for leprosy in healthy controls. Anti-PGL-1 assay was positive in 20 per cent of TT/BT patients and 17.9 per cent of I patients. Anti-35 kDa assay was negative in all the TT/BT patients and positive in 7.14 per cent of I patients. Anti-LAM assay was positive in 13.3 per cent of TT/BT patients and in 10.7 per cent of I patients. Hence, while these assays are valuable in diagnosing BL/LL patients, their usefulness in diagnosing I, BT or TT leprosy is limited. (AU).
Descriptors:MYCOBACTERIUM LEPRAE/imunol
TESTES SOROLOGICOS
ANTICORPOS ANTIBACTERIAS/sangue
ANTIGENOS DE BACTERIAS/imunol
GLICOLIPIDIOS/imunol
HANSENIASE/sangue
HANSENIASE/clas
HANSENIASE/diag
HANSENIASE/imunol
LIPOPOLISSACARIDIOS/imunol
Limits:ESTUDO COMPARATIVO
HUMANO
MASCULINO
FEMININO
ADULTO
MEIA-IDADE
ADOLESCENTE
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 09162/s


  2 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:13719
Author:Kang, T. -J; Kim, S. -K; Lee, S. -B; Chae, G. -T; Kim, J. -P
Title:Comparison of two different PCR amplification products (the 18-kDa protein gene vs. RLEP repetitive sequence) in the diagnosis of Mycobacterium leprae ..-
Source:s.l; s.n; 2003. 5 p. tab.
Abstract:To determine the best molecular method for diagnosing leprosy, two sets of Mycobacterium leprae-specific primers were compared. Fresh biopsies and slit skin smear samples were obtained from 67 leprosy patients and examined by touchdown (TD) PCR using primers amplifying either a 129-bp fragment of the RLEP repetitive sequence or a 360-bp fragment of the 18-kDa protein gene of M. leprae. Seventeen of 30 (56.7 per cent) biopsy specimens and four of 37 (10.8 per cent) slit skin smear specimens were positive using the primer for the 18-kDa protein gene, whereas 24 of 30 (80 per cent) biopsy and 27 of 37 (73 per cent) slit skin smear samples showed detectable PCR products in the RLEP repetitive sequence. Twenty-one of 31 cases (67.7 per cent) with a bacterial index of zero were PCR positive for the primer RLEP repetitive sequence. These results demonstrate that detection of M. leprae using PCR with primers to a RLEP sequence is more sensitive and specific than PCR with the 18-kDa protein gene primers and also slit smears with acid fast staining. PCR of RLEP repetitive sequences is therefore a useful means of detecting M. leprae DNA even when it is present at very low levels. (AU).
Descriptors:ANTICORPOS ANTIBACTERIAS/sangue
PROTEINAS DE BACTERIAS/genet
HANSENIASE/diag
HANSENIASE/microbiol
MYCOBACTERIUM LEPRAE/genet
MYCOBACTERIUM LEPRAE/isol
REACAO EM CADEIA DA POLIMERASE/métodos
PELE/microbiol
SEQUÊNCIAS REPETITIVAS DO ACIDO NUCLEICO
 PRIMERS DO DNA
Limits:ESTUDO COMPARATIVO
HUMANO
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 09117/s


  3 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:13639
Author:Kang, T. -J; Kim, S. -K; Lee, S. -B; Chae, G. -T; Kim, J. -P
Title:Comparison of two different PCR amplification products (the 18-kDa protein gene vs. RLEP repetitive sequence) in the diagnosis of Mycobacterium leprae ..-
Source:s.l; s.n; 2003. 5 p. ilus, tab.
Abstract:To determine the best molecular method for diagnosing leprosy, two sets of Mycobacterium leprae-specific primers were compared. Fresh biopsies and slit skin smear samples were obtained from 67 leprosy patients and examined by touchdown (TD) PCR using primers amplifying either a 129-bp fragment of the RLEP repetitive sequence or a 360-bp fragment of the 18-kDa protein gene of M. leprae. Seventeen of 30 (56.7 per cent) biopsy specimens and four of 37 (10.8 per cent) slit skin smear specimens were positive using the primer for the 18-kDa protein gene, whereas 24 of 30 (80 per cent) biopsy and 27 of 37 (73 per cent) slit skin smear samples showed detectable PCR products in the RLEP repetitive sequence. Twenty-one of 31 cases (67.7 per cent) with a bacterial index of zero were PCR positive for the primer RLEP repetitive sequence. These results demonstrate that detection of M. leprae using PCR with primers to a RLEP sequence is more sensitive and specific than PCR with the 18-kDa protein gene primers and also slit smears with acid fast staining. PCR of RLEP repetitive sequences is therefore a useful means of detecting M. leprae DNA even when it is present at very low levels. (AU).
Descriptors:ANTICORPOS ANTIBACTERIAS/sangue
PROTEINAS DE BACTERIAS/genet
PRIMERS DO DNA
HANSENIASE/diag
HANSENIASE/microbiol
MYCOBACTERIUM LEPRAE/genet
MYCOBACTERIUM LEPRAE/isol
REACAO EM CADEIA DA POLIMERASE/métodos
SEQUÊNCIAS REPETITIVAS DO ACIDO NUCLEICO
PELE/microbiol
Limits:ESTUDO COMPARATIVO
HUMANO
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 09054/s


  4 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:13631
Author:Paige, Christopher F; Scholl, Daniel T; Truman, Richard W
Title:Prevalence and incidence density of Mycobacterium leprae and trypanosoma cruzi infections within a population of wild nine-banded armadillos ..-
Source:s.l; s.n; 2002. 5 p. ilus, tab, graf.
Abstract:A total of 415 wild 9-banded armadillos from the East Atchafalaya River Levee (Point Coupee, LA) were collected over 4 years to estimate the incidence and prevalence of Mycobacterium leprae and Trypanosoma cruzi and to discern any relationship between the 2 agents. M. leprae infections were maintained at a high steady prevalence rate year to year averaging 19 per cent. T. cruzi antibody prevalence remained relatively low, averaging 3.9 per cent, and varied markedly between years. Prevalence rates were independent, with only 3 armadillos coinfected with both agents. M. leprae incidence density ranged from 0.47 to 3.5 cases per 1,000 animal-days, depending on case definition, confirming active intense transmission of M. leprae among armadillos. No incident T. cruzi cases were found. These infections seem to occur independently and may be used in comparisons to understand better factors that may influence transmission of these agents. (AU).
Descriptors:ANTICORPOS ANTIBACTERIAS/anal
ANTICORPOS ANTIPROTOZOARIOS/anal
TATUS/microbiol
DOENCA DE CHAGAS/epidemiol
DOENCA DE CHAGAS/vet
RESERVATORIOS DE DOENCAS/vet
HANSENIASE/epidemiol
HANSENIASE/vet
INCIDÊNCIA
MYCOBACTERIUM LEPRAE/isol
DENSIDADE DEMOGRAFICA
PREVALÊNCIA
ELISA
TRYPANOSOMA CRUZI/isol
Limits:HUMANO
ANIMAL
SUPPORT, NON-U.S. GOV'T
SUPPORT, U.S. GOV'T, P.H.S.
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 09000/s


  5 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:13625
Author:Antunes, Abílio; Nina, Jaime; David, Suzana
Title:Serological screening for tuberculosis in the community: an evaluation of the Mycodot procedure in an African population with high HIV-2 prevalence (Republic of Guinea-Bissau) ..-
Source:s.l; s.n; 2002. 5 p. tab.
Abstract:The immuno-dot-blot assay MycoDot, which detects lipoarabinomannan (LAM) antibodies, was evaluated for the serological diagnosis of active pulmonary tuberculosis in patients in a rural community in the Republic of Guinea-Bissau. Sera from 269 adults (age > 15) and 33 children (age < 5) were assayed for antibodies in a blind manner and the results compared to the clinical status of tuberculosis. The assay had a specificity and a sensitivity of 92.4 per cent and 63.0 per cent respectively, when applied to the adult population. In HIV-2 infected individuals (27/269), the specificity and sensitivity of the assay were similar, 94.7 per cent and 62.5 per cent respectively. The assay did not provide high sensitivity for the diagnosis of tuberculosis in children. Sera from patients with leprosy cross-reacted with the antigen of the assay. It is concluded that this easily performed assay may be useful for the presumptive diagnosis of tuberculosis in adult populations in rural areas of developing countries where routine screening is not readily available. (AU).
Descriptors:ANTICORPOS ANTIBACTERIAS/sangue
GUINE BISSAU
INFECCOES POR HIV/compl
HIV-2
IMMUNOBLOTTING/métodos
LIPOPOLISSACARIDIOS/uso diag
POPULACAO RURAL
MYCOBACTERIUM TUBERCULOSIS/isol
SENSIBILIDADE E ESPECIFICIDADE
TUBERCULOSE/compl
TUBERCULOSE/diag
TUBERCULOSE/patol
TUBERCULOSE/virol
Limits:ESTUDO COMPARATIVO
HUMANO
PRÉ-ESCOLAR
CRIANÇA
ADULTO
SUPPORT, NON-U.S. GOV'T
ADOLESCENTE
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 09016/s


  6 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:13544
Author:Convit, Jacinto; Ulrich, Marian
Title:Recent advances in the immunology of leprosy ..-
Source:s.l; s.n; apr. 1976. 14 p. ilus.
Abstract:For many decades, interest in leprosy has been largely limited to those areas of the tropical and subtropical world where the disease constitutes an important public health problem.(AU).
Descriptors:ANTICORPOS ANTIBACTERIAS
COMPLEXO ANTIGENO-ANTICORPO
REACOES ANTIGENO-ANTICORPO
TECNICAS IMUNOLOGICAS
HANSENIASE/quimioter
HANSENIASE/imunol
HANSENIASE/patol
LINFOCITOS/imunol
MACROFAGOS/imunol
MYCOBACTERIUM LEPRAE/imunol
IMUNIZACAO PASSIVA
 SINDROMES DE DEFICIÊNCIA IMUNOLOGICA/imunol
 IMUNOTERAPIA
 VACINACAO
 IMUNIDADE
 IMUNIDADE CELULAR
 TATUS/imunol
 MODELOS ANIMAIS DE DOENCAS
Limits:HUMANO
ANIMAL
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 00578/s


  7 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:13475
Author:Das, P. K; Ibrahim, A. A; Binkhuysen, F; Thi Hué, P; Qui, T. H; Rangarajan R;; Ruitenberg EJ
Title:The use of subcellular components of BCG for studying host-Mycobacterium interaction in relation to leprosy ..-
Source:s.l; s.n; Jul.-Aug. 1982. 19 p. ilus, tab, graf.
Abstract:Mycobacterium bovis-BCG was sonified and centrifuged at 90,000g for 2h to obtain pellet (P90) and supernatant (S90), and bacilli broken by chilled X-press were fractionated into cell wall (CW), plasma membrane and cytosol. Rabbits were immunized with P90, S90 and whole sonified-broken BCG. The antigenic make-up of these antisera. These analysed by cross-immunoelectrophoresis using the antisera. These subcellular preparations were also used for detecting circulating antibodies in the sera of 45 leprosy patients by Ouchterlony´s technique and immunoelectrophoresis. Although there were many antigenic determinants common to more than one fraction, some components were found in only one fraction. Furthermore, different leprosy patients showed different patterns of antibody response to the antigens in the different fractions. In addition, these fractions were also used to assess cell-mediated immunity in mice sensitized with lyophilized whole BCG as well as with irradiated Mycobacterium. it was found that BCG, intraperitoneally injected, engedered different specifically antigen-sensitized populations of lymphocytes in the spleen and lymph node. Moreover, a certain degree of antigenic cross-reactivity was observed between BCG and M. leprae, possibly at the T-cell level. In vitro experiments suggested that the CW stimulated B cells, indicating a mitogenic ctivity leading to polyclonal activation. Finally, in vitro priming experiments established that these subcellular fractions could sensitize human peripheral lymphocytes, and upon secondary culture all primed cells were able to respond to homologous preparations but not always to heterologous preparations, thus offering a means to distinguish antigens of interest from those antigenically less complicated fractions at the T-cell level.(AU).
Descriptors:MYCOBACTERIUM LEPRAE/imunol
CAMUNDONGOS ENDOGÂMICOS CBA
MYCOBACTERIUM BOVIS/imunol
IMUNOELETROFORESE BIDIMENSIONAL
HANSENIASE/imunol
ANTICORPOS ANTIBACTERIAS/anal
ANTIGENOS DE BACTERIAS/anal
TATUS
FRACOES SUBCELULARES/imunol
Limits:HUMANO
ANIMAL
FEMININO
CAMUNDONGOS
COELHOS
SUPPORT, NON-U.S. GOV'T
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 01556/s


  8 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:13431
Author:Melsom, R; Duncan, M. E; Harboe, M; Bjune, G
Title:Antibodies against Mycobacterium leprae antigen 7 from birth to 18 months of age: an indicator of intra-uterine infection in leprosy ..-
Source:s.l; s.n; oct. 1980. 7 p. tab, graf.
Abstract:All babies of three non-leprosy mothers and ten tuberculoid leprosy mothers and four of five babies of mothers with inactive lepromatous leprosy showed a decline in serum concentration of antibodies against M. leprae antigen 7 during the first 4 months of life, as expected from catabolism of maternal IgG. By contrast, ten of twenty babies of mothers with active lepromatous leprosy showed a decline in concentration of anti-M. leprae 7 antibodies considerably less than expected. This indicates that these babies have been stimulated by M. leprae antigen 7, either as free antigen or by viable M. leprae before birth, and thus that leprosy may occur as a congenital infection. Studies of anti-M. leprae antibodies in repeated serum samples obtained during the first 18 months of life indicated that children of mothers with bacilliferous leprosy are frequently exposed to M. leprae to a sufficient extent to stimulate the immune system of the baby to production of anti-M. leprae antibodies during this period. The consequences of this exposure to M. leprae should be ascertained by careful clinical studies.(AU).
Descriptors:HANSENIASE/imunol
TROCA MATERNO-FETAL
MYCOBACTERIUM LEPRAE/imunol
IMUNOGLOBULINA G/metab
ENVELHECIMENTO
SANGUE FETAL/imunol
ANTIGENOS DE BACTERIAS/imunol
ANTICORPOS ANTIBACTERIAS/anal
Limits:HUMANO
FEMININO
GRAVIDEZ
RECÉM-NASCIDO
LACTENTE
SUPPORT, NON-U.S. GOV'T
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 00461/s


  9 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:13414
Author:Closs, O; Kronvall, G
Title:Experimental murine leprosy ..-
Source:s.l; s.n; 1975. 6 p. ilus, tab.
Abstract:Sera from C3H and C57BL mice infected with Mycobacterium lepraemurium (MLM) and from human leprosy patients were examined for antibodies against MLM by a crossed immunoelectrophoresis (CIE) technique. Altogether antibodies against six or seven MLM antigens were found in the mouse sera. After a small inoculum of MLM, C3H mice produced more antibodies than C57BL mice. After a large inoculum both strains produced about the same amount of antibodies but showed qualitative differences in their response patterns. A serum pool from patients with lepromatous leprosy contained antibodies against six MLM antigens; five of these were identical with the antigens against which antibodies were found in infected mice. C57BL mice that had lost their delayed-type hypersensitivity to MLM during the course of a disseminated infection showed a fairly strong antibody response to three antigens and a weak response to three others. Since almost the same spectrum of antibodies, although in lower titres, could be demonstrated in C57BL mice with intact delayed-type hypersensitivity to the bacilli, these antibodies did not seem to interfere with the expression of cell-mediated immunity.(AU).
Descriptors:MODELOS ANIMAIS DE DOENCAS
ANTIGENOS DE BACTERIAS
ANTICORPOS ANTIBACTERIAS
HIPERSENSIBILIDADE TARDIA/imunol
IMUNIDADE CELULAR
IMUNOELETROFORESE BIDIMENSIONAL
HANSENIASE/imunol
CAMUNDONGOS ENDOGÂMICOS C3H/imunol
CAMUNDONGOS ENDOGÂMICOS C57BL/imunol
MYCOBACTERIUM LEPRAEMURIUM/imunol
Limits:HUMANO
ANIMAL
FEMININO
CAMUNDONGOS
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 00024/s


  10 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:13413
Author:Closs, O; Mshana, R. N; Harboe, M
Title:Antigenic analysis of Mycobacterium leprae ..-
Source:s.l; s.n; mar. 1979. 6 p. ilus.
Abstract:About twenty distinct antigenic components have been demonstrated in Mycobacterium leprae (M. leprae) by crossed immunoelectrophoresis against a rabbit antiserum produced by immunization with concentrated M. leprae antigen. This system allows a more detailed analysis of the antigenic relationship between M. leprae and other mycobacteria and a better characterization of the antigenic content of various M leprae preparations than with previously available anstisera of the antigenic content of various M. leprae preparations than with previously available antisera which reacted with far fewer components. The antibody activity in sera of patients with lepromatous leprosy was studied by incorporating the sera into the intermediate gel of the M. leprae reference system. Antibodies were found against only seven of the components. Since those compared are all known to be cross-reacting widely with antigens of other mycobacteria, it is speculated that cross-immunization may influence the antibody response in lepromatous leprosy.(AU).
Descriptors:IMUNOELETROFORESE BIDIMENSIONAL
SOROTIPAGEM
ANTIGENOS DE BACTERIAS/anal
FRAGMENTOS DE IMUNOGLOBULINAS
ANTICORPOS ANTIBACTERIAS
MYCOBACTERIUM LEPRAE/imunol
Limits:ANIMAL
COELHOS
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 00025/s


  11 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:13354
Author:Holmes, I. B; Banerjee, D. K; Hilson, G. R
Title:Effect of rifampin, clofazimine, and B1912 on the viability of Mycobacterium leprae in established mouse footpad infection ..-
Source:s.l; s.n; apr. 1976. 5 p. graf.
Abstract:Continuous dietary administration of rifampin to mice with an established Mycobacterium leprae footpad infection reduced the bacillary solid ratio, with an estimated survival half-life of 5-6 days. In rifampin-treated immunosuppressed animals the survival half-life of solid bacilli, in the absence of host immunity, was 12-13 days. Clofazimine and B1912 produced a significant effect on solid ratio only after a lag period of apparently 100 days. The rate of action was considerably slower than that of rifampin. Intermittent (once monthly) administration of both drugs produced effects similar to those of continuous administration.(AU).
Descriptors:ANTICORPOS ANTIBACTERIAS
CLOFAZIMINA/analog
CLOFAZIMINA/farmacol
CLOFAZIMINA/uso terap
IMUNOSSUPRESSAO
HANSENIASE/quimioter
HANSENIASE/imunol
MYCOBACTERIUM LEPRAE/ef drogas
MYCOBACTERIUM LEPRAE/imunol
FATORES DE TEMPO
RIFAMPINA/farmacol
RIFAMPINA/uso terap
Limits:ESTUDO COMPARATIVO
ANIMAL
CAMUNDONGOS
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 01652/s


  12 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:13278
Author:Waters, M. F. R; Isa, Bakri Bin HJ; Rees, R. J. W; McDougall, A. C
Title:Experimental lepromatous leprosy in the white-handed gibbon (Hylobatus lar): successful inoculation with leprosy bacilli of human origin ..-
Source:s.l; s.n; dec. 1978. 7 p. ilus, tab.
Abstract:Leprosy bacilli of human origin were inoculated into a white-handed gibbon by the i.v. and i.p. routes, and also locally into ears, testis and around an ulnar nerve. The animal was observed closely during a period of nearly 15 years and did not exhibit any clinical evidence of cutaneous or neurological disease. At death, a wide range of tissues was taken for bacterial counts and histological examination, and a disseminated and progressive infection was demonstrated. Acid-fast bacilli were found in many sites; their morphological appearance, distribution in nerves, and pattern of multiplication in mouse foot-pads, and also the presence of anti-mycobacterial antibody in the serum and the absence of specific lymphocyte transformation were all in keeping with an infection by Mycobacterium leprae, at an early lepromatous infection in a primate. The findings are discussed in relation to the long incubation period of lepromatous leprosy and the difficulties of diagnosing the disease at an early stage in man.(AU).
Descriptors:ANTICORPOS ANTIBACTERIAS/anal
MODELOS ANIMAIS DE DOENCAS
MEMBRO POSTERIOR/patol
HYLOBATES/anat
HANSENIASE/imunol
HANSENIASE/patol
MYCOBACTERIUM LEPRAEMURIUM/isol
MYCOBACTERIUM LEPRAEMURIUM/patogen
PONGIDAE/anat
NERVO ULNAR
Limits:ANIMAL
MASCULINO
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 00546/s


  13 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:12549
Author:Singh, N. B; Bhatnagar, Shalini; Choudhary, Anita; Gupta, H. P; Kaul, S. M
Title:Evaluation of diversified antigens for detection of Mycobacterium leprae antibodies from leprosy patients and contacts ..-
Source:s.l; s.n; 1994. 4 p. tab, graf.
Descriptors:ANTICORPOS ANTIBACTÉRIAS
REAÇOES ANTIGENO-ANTICORPO
BUSCA DE COMUNICANTE
ESTUDOS DE AVALIAÇAO
HANSENIASE
HANSENIASE
MYCOBACTERIUM LEPRAE
Limits:ADOLESCENCIA
ADULTO
FEMININO
HUMANO
MASCULINO
MEIA-IDADE
Location:BR191.1; 06967/s


  14 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:12308
Author:Blatt, Jucelene Marchi
Title:Considerações acerca dos estados reacionais do portador de hanseníase no município de Itajaí Considerations on reactional states of Itajai's hansen's carriers-
Source:s.l; s.n; 2001. 10 p. tab.
Descriptors:HANSENIASE
PROGRAMAS MÉDICOS REGIONAIS
AVALIAÇAO DE PROCESSOS E RESULTADOS (CUIDADOS DE SAUDE)
RESULTADO DE TRATAMENTO
REGISTROS MÉDICOS
MYCOBACTERIUM LEPRAE
TALIDOMIDA
CLOFAZIMINA
RIFAMPINA
DAPSONA
ANTICORPOS ANTIBACTÉRIAS
RELAÇAO DOSE-RESPOSTA IMUNOLOGICA
Location:BR191.1; 08738/s


  15 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:12258
Author:Tovar-Rivera, T; Sánchez-Colón, S; Padierna-Olivos, L; Massó-Rojas, F; Estrada-Parra, S; Mondragón-González, R; Jiménez-Martínez, M. C; Sánchez-García, F. J
Title:Connectivity patterns in tuberculosis and leprosy patients are indistinguishable from that of healthy donors ..-
Source:s.l; s.n; 2001. 8 p. graf.
Descriptors:ANTICORPOS ANTIBACTÉRIAS
ANTICORPOS ANTIBACTÉRIAS
ESPECIFICIDADE DE ANTICORPOS
ANTIGENOS DE BACTÉRIAS
IMUNOGLOBULINAS FAB
ENFOQUE ISOELÉTRICO
HANSENIASE
MYCOBACTERIUM LEPRAE
MYCOBACTERIUM TUBERCULOSIS
TUBERCULOSE PULMONAR
Imunoglobulina G/BI
Imunoglobulina G/BI
Mycobacterium tuberculosis/IM
Tuberculose Pulmonar/*IM
Location:BR191.1; 08691/s


  16 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:11945
Author:Lockwood, Diana N. J; Colston, M. J; Khanolkar-Young, S. R
Title:The detection of Mycobacterium leprae protein and carbohydrate antigens in skin and nerve from leprosy patients with type 1 (reversal) reactions ..-
Source:s.l; s.n; 2002. 7 p. ilus, tab.
Descriptors:HANSENIASE DIMORFA
HANSENIASE DIMORFA
MYCOBACTERIUM LEPRAE
MYCOBACTERIUM LEPRAE
ANTICORPOS ANTIBACTÉRIAS
ANTICORPOS MONOCLONAIS
ANTIGENOS DE BACTÉRIAS
BIOPSIA
CHAPERONINAS
CHAPERONINAS
HIPERSENSIBILIDADE TARDIA
IMUNOHISTOQUIMICA
LIPOPOLISSACARIDIOS
LIPOPOLISSACARIDIOS
MACROFAGOS
NERVOS PERIFÉRICOS
NERVOS PERIFÉRICOS
CÉLULAS DE SCHWANN
PELE
PELE
Location:BR191.1; 08600/s


  17 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:11732
Author:Drowart, A; Huygen, K; Launois, P; Jann, E; Nyabenda, J; van Vooren, J. P
Title:IgG humoral response against the antigen 85 complex homologues in leprosy ..-
Source:s.l; s.n; 1994. 5 p. tab, graf.
Descriptors:HANSENIASE
MYCOBACTERIUM
ANTICORPOS ANTIBACTÉRIAS
ANTICORPOS MONOCLONAIS
ANTIGENOS DE BACTÉRIAS
WESTERN BLOTTING
REAÇOES CRUZADAS
IGG
ENFOQUE ISOELÉTRICO
Location:BR191.1; 06972/s


  18 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:11617
Author:Tovar-Rivera, T; Sánchez-Colón, S; Padierna_olivos, L; Massó-Rojas, F; Estrada-Parra, S; Mondragón-Gonzáles, R; Jiménez-Martínez, M. C; Sánchez_garcía, F. J
Title:Connectivity patterns in tuberculosis and leprosy patients are indistinguishable from that of healthy donors ..-
Source:s.l; s.n; 2001. 8 p. graf.
Descriptors:ANTICORPOS ANTIBACTÉRIAS
ANTICORPOS ANTIBACTÉRIAS
ESPECIFICIDADE DE ANTICORPOS
ANTIGENOS DE BACTÉRIAS
IMUNOGLOBULINAS FAB
ENFOQUE ISOELÉTRICO
HANSENIASE
MYCOBACTERIUM LEPRAE
MYCOBACTERIUM TUBERCULOSIS
TUBERCULOSE PULMONAR
Imunoglobulina G/BI
Imunoglobulinas Fab/IM
Location:BR191.1; 08440/s


  19 / 94 HANSEN  
              first record previous record next record last record
select
to print
Id:11430
Author:Blatt, Jucelene Marchi
Title:Considerações acerca dos estados reacionais do portador de hanseníase no Município de Itajaí Considerations on reactional states of Itajai's hansen's carriers-
Source:s.l; s.n; 2001. 10 p. tab.
Descriptors:HANSENIASE
PROGRAMAS MÉDICOS REGIONAIS
AVALIAÇAO DE PROCESSOS E RESULTADOS (CUIDADOS DE SAUDE)
RESULTADO DE TRATAMENTO
REGISTROS MÉDICOS
MYCOBACTERIUM LEPRAE
TALIDOMIDA
RIFAMPINA
DAPSONA
ANTICORPOS ANTIBACTÉRIAS
RELAÇAO DOSE-RESPOSTA IMUNOLOGICA
CRIANÇA
Location:BR191.1; 08312/s


  20 / 94 HANSEN  
              first record previous record
select
to print
Id:11334
Author:Kirsztajn, G. M; Nishida, S. K; Silva, M. S; Lombardi, C; Ajzen, H; Pereira, A. B
Title:Specific and nonspecific aspects of humoral immune response in leprosy ..-
Source:s.l; s.n; 1994. 12 p. graf.
Descriptors:ADOLESCENCIA
ANTICORPOS ANTINUCLEARES
ANTICORPOS ANTIBACTÉRIAS
PROTEINA C-REATIVA
CRIANÇA
RELAÇOES HOSPEDEIRO-PARASITA
HANSENIASE
HANSENIASE
HANSENIASE LEPROMATOSA
HANSENIASE LEPROMATOSA
MYCOBACTERIUM LEPRAE
FATOR REUMATOIDE
SENSIBILIDADE E ESPECIFICIDADE
Location:BR191.1; 06946/s



page 1 de 5 go to page              
   


Refine the search
  Database : HANSEN Advanced form   
Search for : Free form   

    Search in field  
1  
2
3
 
           



Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO
Latin American and Caribbean Center on Health Sciences Information